Canopy Growth (TSE:WEED – Free Report) had its price target trimmed by ATB Capital from C$4.00 to C$3.20 in a research note published on Monday morning,BayStreet.CA reports. The brokerage currently has an underperform rating on the stock.
Separately, Canaccord Genuity Group lowered their price objective on shares of Canopy Growth from C$2.50 to C$1.50 and set a “sell” rating for the company in a research note on Monday. Four research analysts have rated the stock with a sell rating and one has assigned a hold rating to the company’s stock. According to MarketBeat, Canopy Growth presently has a consensus rating of “Reduce” and a consensus target price of C$5.40.
Check Out Our Latest Stock Report on WEED
Canopy Growth Price Performance
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Articles
- Five stocks we like better than Canopy Growth
- What Investors Need to Know to Beat the Market
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Want to Profit on the Downtrend? Downtrends, Explained.
- Inflation Persists, But So Do Stock Opportunities: Rally On
- 3 Tickers Leading a Meme Stock Revival
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.